December 08, 2015 (Shareholders Foundation) - An investigation on behalf of investors of Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN) shares over potential securities laws violations by Aoxing Pharmaceutical Company and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN) concerning whether a series of statements by Aoxing Pharmaceutical Company regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Aoxing Pharmaceutical Company Inc reported that its Total Revenue rose from $12.74 million for the 12 months period that ended on June 30, 2014 to $25.48 million for the 12 months period that ended on June 30, 2015 and that its Net Loss of $8.22 million for the 12 months period that ended on June 30, 2014 turned into a Net Income of $5.49 million for the 12 months period that ended on June 30, 2015.

Shares of Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN0 reached as high as $2.78 per share in June 2015.

On December 1, 2015, post-market, Aoxing Pharmaceutical Company Inc reported the resignation of Wilfred Chow, the Company's Chief Financial Officer, on November 30, 2015.

Shares of Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN) declined to as low as $0.98 per share on December 3, 2015.